Home  »  Company  »  Lincoln Pharmaceuticals Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Lincoln Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 510.31 472.08 413.06 376.09 353.04
Manufacturing Expenses 10.25 8.33 6.84 7.57 7.08
Personnel Expenses 93.16 70.47 56.47 54.90 48.40
Selling Expenses 1.16 0.06 0.05 0.19 0.28
Administrative Expenses 73.48 77.96 67.02 66.80 59.21
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 421.14 376.61 331.71 316.72 292.71
Operating Profit 89.17 95.47 81.35 59.37 60.33
Other Recurring Income 22.48 10 6.77 12.13 6.58
Adjusted PBDIT 111.65 105.47 88.12 71.50 66.90
Financial Expenses 2.03 1.45 1.44 1.98 3.84
Depreciation 9.17 8.09 5.67 5.47 4.92
Other Write offs 0 0 0 0 0
Adjusted PBT 100.46 95.93 81.01 64.05 58.14
Tax Charges 27.56 26.57 20.61 14.48 11.51
Adjusted PAT 72.90 69.36 60.41 49.56 46.64
Non Recurring Items -0.48 0.13 0 0 0
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 72.90 69.36 60.41 49.56 46.64
Equity Dividend 3 3 0 4.77 2.38
Preference Dividend 0 0 0 0 0
Retained Earnings 417.68 338.31 272.33 213.66 171.21

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X